Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SSSS
SSSS logo

SSSS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy SuRo Capital Corp (SSSS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.210
1 Day change
2.40%
52 Week Range
14.980
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

SuRo Capital Corp (SSSS) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the stock has shown some positive momentum in recent price changes and analysts have raised price targets, insider selling and lack of strong technical signals suggest caution. Additionally, the absence of recent news or significant financial performance data limits the ability to assess its growth potential comprehensively.

Technical Analysis

The MACD is negatively contracting, RSI is neutral at 38.75, and moving averages are converging. The stock is trading near its pivot level of 13.561, with resistance at 14.161 and support at 12.961. There is no clear upward or downward trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
7

Positive Catalysts

  • The stock is trading at a discount to its net asset value (NAV), which could indicate upside potential.

Neutral/Negative Catalysts

  • Insiders have increased selling by 108.29% over the last month, which may indicate a lack of confidence in the stock's near-term performance. Technical indicators do not show a strong bullish trend, and there is no recent news or Congress trading data to support a buy decision.

Financial Performance

No financial performance data is available for analysis due to a data error.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have raised price targets multiple times recently, with the highest target at $18. Ratings remain positive with 'Outperform' and 'Buy' recommendations, driven by expectations of portfolio mark-ups and monetization events in 2026.

Wall Street analysts forecast SSSS stock price to fall
3 Analyst Rating
Wall Street analysts forecast SSSS stock price to fall
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 12.900
sliders
Low
10.5
Averages
11.5
High
12
Current: 12.900
sliders
Low
10.5
Averages
11.5
High
12
Barrington
Outperform
maintain
$17 -> $18
AI Analysis
2026-05-06
Reason
Barrington
Price Target
$17 -> $18
AI Analysis
2026-05-06
maintain
Outperform
Reason
Barrington raised the firm's price target on SuRo Capital to $18 from $17 and keeps an Outperform rating on the shares after the company announced Q1 results. Noting that private markets remain "highly robust" with continued strength in large-scale financings, the firm expects further portfolio mark-ups and monetization events in 2026, including the expected 2026 IPO of OpenAI, currently SuRo's second largest position, the analyst tells investors.
BTIG
Buy
maintain
$15
2026-04-09
Reason
BTIG
Price Target
$15
2026-04-09
maintain
Buy
Reason
BTIG raised the firm's price target on SuRo Capital to $15 from $12.50 and keeps a Buy rating on the shares. The firm is citing the company's landmark partnership with an $18B asset manager that will see SuRo shift back to an externally-managed model, with the change not only reducing operating expenses but, more importantly, providing SuRo greater investment sourcing and due diligence capabilities, the analyst tells investors in a research note. This transaction will also enable SuRo shareholders to benefit from the asset manager's access to the most attractive, but hardest-to-access, private market opportunities, including AI infrastructure, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SSSS
Unlock Now

People Also Watch